Literature DB >> 3486725

Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.

P Camici, L I Araujo, T Spinks, A A Lammertsma, J C Kaski, M J Shea, A P Selwyn, T Jones, A Maseri.   

Abstract

Regional myocardial perfusion and exogenous glucose uptake were assessed with rubidium-82 (82Rb) and 18F-2-fluoro-2-deoxyglucose (FDG) in 10 normal volunteers and 12 patients with coronary artery disease and stable angina pectoris by means of positron emission tomography. In patients at rest, the myocardial uptake of 82Rb and FDG did not differ significantly from that measured in normal subjects. The exercise test performed within the positron camera in eight patients produced typical chest pain and ischemic electrocardiographic changes in all. In each of the eight patients a region of reduced cation uptake was demonstrated in the 82Rb scan recorded at peak exercise, after which uptake of 82Rb returned to the control value 5 to 14 min after the end of the exercise. In these patients, FDG was injected in the recovery phase when all the variables that were altered during exercise, including regional myocardial 82Rb uptake, had returned to control values. In all but one patient, FDG accumulation in the regions of reduced 82Rb uptake during exercise was significantly higher than that in the nonischemic regions, i.e., the ones with a normal increment of 82Rb uptake on exercise. In the nonischemic areas, FDG uptake was not significantly different from that found in normal subjects after exercise. In conclusion, myocardial glucose transport and phosphorylation seem to be enhanced in the postischemic myocardium of patients with exercise-induced ischemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486725     DOI: 10.1161/01.cir.74.1.81

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  58 in total

1.  Exercise-induced myocardial ischemia: can this be imaged with F-18-fluorodeoxyglucose?

Authors:  D Jain; P H McNulty
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

2.  F-18 fluorodeoxyglucose imaging in myocardial ischemia: beyond myocardial viability.

Authors:  J A Arrighi
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

Review 3.  Evidence that stunning can be cumulative in man.

Authors:  C Aldo Rinaldi; Roger J C Hall
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

Review 4.  Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure.

Authors:  Steven Burrell; Sharmila Dorbala; Marcelo F Di Carli
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

Review 5.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

6.  Diagnostic value of left ventricular function after stress and at rest in the detection of multivessel coronary artery disease as assessed by electrocardiogram-gated SPECT.

Authors:  Satoshi Hida; Taishiro Chikamori; Hirokazu Tanaka; Yasuhiro Usui; Yuko Igarashi; Tadashi Nagao; Akira Yamashina
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

7.  Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome.

Authors:  Kevin A Bybee; Joseph Murphy; Abhiram Prasad; R Scott Wright; Amir Lerman; Charanjit S Rihal; Panithaya Chareonthaitawee
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

Review 8.  Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Authors:  Keiichiro Yoshinaga; Masanao Naya; Tohru Shiga; Eriko Suzuki; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-12       Impact factor: 9.236

9.  Paradoxical uptake of F-18 fluorodeoxyglucose by successfully reperfused myocardium during the sub-acute phase in patients with acute myocardial infarction.

Authors:  K Hashimoto; T Uehara; Y Ishida; H Nonogi; H Kusuoka; T Nishimura
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

10.  Cardiac ischemia. Part I--Metabolic and physiologic responses.

Authors:  G A Langer; J N Weiss; H R Schelbert
Journal:  West J Med       Date:  1987-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.